In a fibromyalgia patient who tapered baclofen from 20 mg extended‑release twice daily to 10 mg extended‑release four days ago and stopped a two‑month guaifenesin regimen two days ago, could the sudden restlessness and anxiety be due to baclofen withdrawal rather than guaifenesin discontinuation?

Baclofen Withdrawal is the Most Likely Cause of Your Symptoms

Your sudden restlessness and anxiety are almost certainly due to baclofen withdrawal, not guaifenesin discontinuation. Baclofen is a centrally-acting muscle relaxant that can cause significant withdrawal symptoms when tapered too rapidly, and your 50% dose reduction over just 4 days represents an abrupt taper that puts you at high risk for withdrawal syndrome 1.

Why Baclofen Withdrawal is the Culprit

Timing and Symptom Profile Match Baclofen Withdrawal

• Baclofen withdrawal syndrome characteristically presents with anxiety, restlessness, and agitation—exactly what you experienced 2, 1, 3
• Your symptoms began 4 days after reducing your dose by 50% (from 20mg ER twice daily to 10mg ER once daily), which is consistent with the typical onset of withdrawal symptoms 1
• The FDA label specifically lists confusion, insomnia, and neuropsychiatric symptoms as adverse reactions to baclofen changes 4

Baclofen Withdrawal Can Be Serious

• Abrupt or rapid baclofen discontinuation can cause rebound anxiety, hallucinations, seizures, and in rare cases, death—making this a potentially dangerous situation 2
• Neurological manifestations of baclofen withdrawal include seizures, psychosis, hallucinations, and visual disturbances 3
• The risk is particularly high when patients have been on chronic baclofen therapy, as you have been 1, 3

Why Guaifenesin is Unlikely the Cause

• There is no established withdrawal syndrome associated with guaifenesin discontinuation in the medical literature
• Guaifenesin is an expectorant with no significant central nervous system effects that would cause withdrawal symptoms
• The "guaifenesin protocol" for fibromyalgia lacks robust evidence for efficacy and has no documented withdrawal profile 5, 6, 7

Your Taper Was Too Rapid

Recommended Tapering Guidelines

• The CDC and Mayo Clinic recommend reducing baclofen by no more than 10% per week for patients on long-term therapy 2
• For patients who have taken baclofen long-term, tapers should be completed over several months, not days 2
• A commonly used safe tapering schedule is a 25% reduction every 1-2 weeks, not 50% in 4 days 2
• Your reduction from 40mg total daily dose to 10mg daily (75% reduction) in 4 days was far too aggressive 2

Baclofen Withdrawal Requires Gradual Tapering

• Baclofen should be tapered gradually because abrupt withdrawal can be associated with serious complications including seizures 2
• The Mayo Clinic consensus panel specifically warns that abrupt cessation of baclofen can cause significant morbidity and even death 2
• Muscle relaxants like baclofen are classified as central nervous system depressants whose abrupt cessation requires the same caution as benzodiazepines 2

Immediate Management Recommendations

Restore Adequate Baclofen Dosing

• Contact your prescribing physician immediately to discuss returning to a higher baclofen dose to stabilize your symptoms 1, 3, 8
• Baclofen withdrawal syndrome is most effectively treated by re-initiation or supplementation of baclofen dosing 1
• Historical case reports show that patients with baclofen withdrawal hallucinations responded within 23-31 hours after reinstituting baclofen 8
• Your use of 5mg IR baclofen was appropriate as a rescue measure, but you need a systematic plan to stabilize at a higher maintenance dose 1

Proper Taper Strategy Going Forward

• Once symptoms stabilize, implement a much slower taper of approximately 10% of the current dose per month 2
• For example, if you stabilize at 20mg ER twice daily (40mg total), reduce by only 4mg every 2-4 weeks 2
• Monitor closely for withdrawal symptoms including anxiety, restlessness, insomnia, confusion, tremor, tachycardia, and muscle pain 2, 4
• The taper may need to be paused or slowed if withdrawal symptoms emerge 2

Adjunctive Symptom Management

• If anxiety persists despite baclofen dose adjustment, consider evidence-based psychotherapies (cognitive behavioral therapy) or antidepressants rather than benzodiazepines 2
• Pharmacologic adjuncts may be required to treat associated withdrawal symptoms, though baclofen restoration is the primary treatment 1
• Close monitoring is essential—follow-up should occur at least monthly during any taper 2

Critical Safety Considerations

Risk of Severe Complications

• Baclofen withdrawal can progress to seizures, hallucinations, and altered consciousness if not properly managed 1, 3, 9, 10
• The FDA adverse event data shows that severe neurological adverse events with baclofen are more common than non-severe ones 10
• Most baclofen-related adverse events occur within the first 27 days of dose changes 10

Do Not Attempt Further Dose Reductions Now

• Attempting to continue tapering while experiencing withdrawal symptoms significantly increases the risk of serious complications 2
• The goal now is stabilization, not continued dose reduction 2
• Any future taper must be done under close medical supervision with a much more gradual schedule 2

When to Seek Emergency Care

• Seek immediate emergency care if you develop confusion, hallucinations, seizures, severe agitation, or altered consciousness 1, 3, 9
• These represent potentially life-threatening complications of baclofen withdrawal 2, 1

Alternative Approaches for Fibromyalgia

Evidence-Based Fibromyalgia Treatments

• Baclofen is not a first-line or evidence-based treatment for fibromyalgia 2, 5, 6
• The EULAR guidelines recommend duloxetine, milnacipran (SNRIs), pregabalin, or amitriptyline as first-line pharmacological options for fibromyalgia 2
• Strong opioids and muscle relaxants receive a "strong against" recommendation for fibromyalgia due to lack of efficacy evidence and high risk of side effects 2

Once Safely Tapered Off Baclofen

• Consider transitioning to evidence-based fibromyalgia treatments including SNRIs (duloxetine 60mg daily) or pregabalin 2, 5
• Non-pharmacological interventions including exercise, cognitive behavioral therapy, and patient education are essential components of fibromyalgia management 2, 6
• Multimodal approaches combining pharmacological and non-pharmacological strategies provide the best outcomes 5, 6, 7